Similar safety results of capecitabine/cisplatin (XP) vs. continuous infusion of 5-FU/cisplatin (FP) from a phase III trial in patients (pts) with previously untreated advanced gastric cancer (AGC)

被引：0
|
作者：
Kang, Y. K.
Kang, W. K.
Shin, D. B.
Chen, J.
Xiong, J.
Wang, J.
Lichinitser, M.
Salas, M. P.
Suarez, T.
Santamaria, J.
机构：
[1] Asan Med Ctr, Dept Internal Med, Seoul, South Korea
[2] Samsung Med Ctr, Dept Internal Med, Ilwon Dong, South Korea
[3] Gachon Med Sch, Gil Med Ctr, Dept Internal Med, Guwal Dong, South Korea
[4] Jiangsu Canc Hosp, Jiangsu, Peoples R China
[5] 1st Affiliated Hosp, Jianxi Med Coll, Jianxi, Peoples R China
[6] Shanghai Changzheng Hosp, Shanghai, Peoples R China
[7] Russian Canc Res Ctr, Blokhin Canc Res Ctr, Moscow, Russia
[8] Hosp Sabogal, Lima, Peru
[9] Ctr Med Pensiones, Yucatan, Mexico
[10] Inst Oncol Nacl, Ancon, Panama
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：205 / 205
页数：1
相关论文
共 50 条
  • [1] Randomized phase III trial of capecitabine/cisplatin (XP) vs. continuous infusion of 5-FU/cisplatin (FP) as first-line therapy in patients (pts) with advanced gastric cancer (AGC): Efficacy and safety results
    Kang, Y.
    Kang, W.
    Shin, D.
    Chen, J.
    Xiong, J.
    Wang, J.
    Lichinitser, M.
    Salas, M.
    Suarez, T.
    Santamaria, J.
    ANNALS OF ONCOLOGY, 2006, 17 : 19 - 19
  • [2] Randomized phase III trial of capecitabine/cisplatin (XP) vs. continuous infusion of 5-FU/cisplatin (FP) as first-line therapy in patients (pts) with advanced gastric cancer (AGC): Efficacy and safety results.
    Kang, Y.
    Kang, W. K.
    Shin, D. B.
    Chen, J.
    Xiong, J.
    Wang, J.
    Lichinitser, M.
    Salas, M. P.
    Suarez, T.
    Santamaria, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 183S - 183S
  • [3] Capecitabine/cisplatin vs. continuous infusion of 5-FU/cisplatin as first-line therapy in patients (pts) with advanced gastric cancer (AGC):: a randomised phase III trial
    Kang, Y.
    Kang, W.
    Shin, D.
    Chen, J.
    Xiong, J.
    Wang, J.
    Lichinitser, M.
    Philco, M.
    Suarez, T.
    Santamaria, J.
    EJC SUPPLEMENTS, 2007, 5 (04): : 259 - 259
  • [4] Randomized phase III trial of capecitabine/cisplatin (XP) vs. continuous infusion of 5-FU/cisplatin (FP) as first-line therapy in patients (PTS) with advanced gastric cancer (AGC):: Subgroup analyses confirm main efficacy findings
    Kang, Yoon Koo
    Kang, Won Ki
    Shin, Dong Bok
    Chen, Jia
    Xiong, Jianping
    Wang, Jie Jun
    Lichinitser, Mikhail
    Philco, Manuel
    Suarez, Tirso
    Santamaria, Julio
    ANNALS OF ONCOLOGY, 2006, 17 : 308 - 308
  • [5] Pharmacoeconomic analysis of treating advanced gastric cancer (AGC) with capecitabine/cisplatin (XP) vs. 5-FU/cisplatin (FP) regimens in an Italian setting
    Garrison, L. P.
    Cirrincione, A.
    Giuliani, G.
    VALUE IN HEALTH, 2007, 10 (03) : A127 - A127
  • [6] Economic evaluation of the cost of treating advanced gastric cancer (AGC) with capecitabine/cisplatin (XP) vs. 5-FU/cisplatin (FP) regimens in an Italian setting
    Giuliani, G.
    Falcone, A.
    Garrison, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] COST MINIMIZATION ANALYSIS (CMA) OF CAPECITABINE/CISPLATIN (XP) VS. 5-FU/CISPLATIN (FP) REGIMENS IN ADVANCED GASTRIC CANCER (AGC) TREATMENT IN THE ROMANIAN SETTING
    Curescu, S.
    Stanculeanu, D. L.
    Croitoru, A.
    Radu, C. P.
    VALUE IN HEALTH, 2011, 14 (07) : A453 - A453
  • [8] COST MINIMIZATION ANALYSIS OF ADVANCED GASTRIC CANCER TREATMENT WITH CAPECITABINE/CISPLATIN (XP) VS. 5-FU/CISPLATIN (FP) REGIMENS IN POLISH SETTING
    Kawalec, P.
    Szawlowski, A.
    Federowicz, I
    Szkultecka-Debek, M.
    Russel-Szymczyk, M.
    VALUE IN HEALTH, 2008, 11 (06) : A473 - A473
  • [9] Cost of treating advanced gastric cancer (AGC) with capecitabine/cisplatin vs. 5-FU/cisplatin regimens: An economic evaluation from an Italian perspective
    Giuliani, G.
    Falcone, A.
    Cirrincione, A.
    Garrison, L.
    EJC SUPPLEMENTS, 2007, 5 (04): : 265 - 265
  • [10] Phase I Irinotecan, Cisplatin and protracted infusion 5-FU (ICF) in advanced gastric cancer (AGC)
    Fernandez Martos, Carlos
    Segura, Angel
    Aparicio, Jorge
    Molins, Carmen
    Busquier, Isabel
    Poveda, Andres
    Balcells, Miquel
    ANNALS OF ONCOLOGY, 2004, 15 : 238 - 238
12345